Publications

The fortnightly Australian Influenza Surveillance Report (AISR) includes information about influenza activity, severity, impact, at-risk populations, virology, and vaccine match and effectiveness. It also gives year-to-date data and comparisons.

This fact sheet covers questions and answers for general practices under the Practice Incentives Program (PIP) Quality Improvement (QI) Incentive.

The fact sheet answers questions about the Practice Incentives Program (PIP) Quality Improvement (QI) Incentive for Aboriginal Community Controlled Health Services (ACCHS) and other organisations funded through the Indigenous Australians' Health Programme (IAHP).

This report presents the financial assistance provided from the MRFF Special Account during the period that the Australian Medical Research and Innovation Priorities 2016–2018 (2016–2018 Priorities) were active, specifically from November 2016 until November 2018.

These terms of reference outline what the National Suicide Prevention Adviser will do, and timeframes for deliverables.

This evaluation plan specifies the design of the evaluation of the Health Care Homes trial, including questions to be answered, methods to be used, measures to show changes, sources of data, and how the statistical and qualitative analysis will be done.

Natural Therapies Review Expert Advisory Panel (NTREAP) meeting outcomes for 11 September 2019 meeting.

The fortnightly Australian Influenza Surveillance Report (AISR) includes information about influenza activity, severity, impact, at-risk populations, virology, and vaccine match and effectiveness. It also gives year-to-date data and comparisons.

The guidelines contain expert consensus on the evidence in relation to healthcare workers and their bloodborne virus (BBV) status. Recommendations include measures related to preventing transmission, managing and treating BBV in healthcare workers.

This document shows priority areas of growth for Commonwealth Home Support Programme (CHSP) services in each region.

This communique summarises the second meeting of the National Dust Disease Taskforce, held on 12 September 2019.

This document explains why we consider the strategic areas for action identified in the National Health Genomics Policy Framework to be a priority. It also provides background for readers who are less familiar with genomics.

This implementation plan describes actions that will support Australia achieving the goals of the National Health Genomics Policy Framework. It includes 28 actions that will allow governments to prioritise activities and address current and emerging issues.

A message from the Prime Minister's National Suicide Prevention Adviser, Ms Christine Morgan, for World Suicide Prevention Day 2019.

This newsletter outlines recent changes to the Medicare Benefits Schedule (MBS) as a result of the MBS Review.

The Terms of Reference for the RAC Funding Reform Working Group.

The Terms of Reference for the Natural Therapies Review Expert Advisory Panel (NTREAP).

Trachoma is the world’s leading infectious cause of preventable blindness. In Australia, it affects mostly Aboriginal and Torres Strait Islander people. This document reports on the prevalence of trachoma in Australia in 2018.

The fortnightly Australian Influenza Surveillance Report (AISR) includes information about influenza activity, severity, impact, at-risk populations, virology, and vaccine match and effectiveness. It also gives year-to-date data and comparisons.

Communiques for the Prostheses List Reform Governance Group meetings.

The National Strategic Action Plan for Macular Disease proposes a national response to macular disease across all levels of government in Australia. It recommends action in 4 major areas.

The operational framework outlines the aims, objectives, outcome parameters and governance of the Specialist Training Program, as well as updated information on funding activities and earlier application rounds.

This report shows the monthly growth in ACFI subsidies compared to estimates for September 2019.

The Initial Assessment and Referral Decision Support Tool (IAR-DST) provides an evidence based tool for conducting initial assessment and referral of individuals presenting with mental health conditions in primary health care settings within Australia.

This communiqué summarises the meeting of the Australian Medical Research Advisory Board (AMRAB) held on 26 July 2019.